A third phenotypic variant, the gray phenotype has recently been identified [229]
Before GLP-1 receptor agonists dominated diabetes care, DPP-4 inhibitors quietly laid the foundation for incretin-based therapy
Elevated MMA can be a marker for low B12
It surveyed 1,171 of its physician telemedicine users and 131 of its nurse practitioner telemedicine users in August
A valid stability-indicating method must: Resolve the main peptide from all degradation products Detect impurities at low regulatory thresholds Accurately quantify impurities even in stressed samples Forced degradation samples are therefore essential during method development and validation for GLP-1 peptide drugs
Patients who self-administer without training may inject at incorrect depths, fail to properly sanitize the injection site, or reuse needles, all of which increase the risk of complications